Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of metabolic disorders. This therapy works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://adrianagjri246831.howeweb.com/39666016/retaglutide-a-promising-glp-1-receptor-agonist